Integra LifeSciences
IART • NASDAQ
Integra LifeSciences is a medical - devices company in the healthcare sector trading on NASDAQ, led by CEO Mojdeh Poul, with a market cap of $717.0M.
CEOMojdeh Poul
Next Earnings
Upcoming earnings announcement for Integra LifeSciences
Date
Monday, May 4, 2026 (in a month)
Timing
Before Market Open (6:00 AM New York)
Fiscal Period
Q1 2026
EPS Estimate
$0.41
Revenue Estimate
$382.3M
Earnings History
Past 12 earnings reports for Integra LifeSciences
| Date | Period | EPS | EPS Surprise | Revenue | Rev. Surprise | Filing |
|---|---|---|---|---|---|---|
| Feb 26, 2026 | Q4 2025 | $0.83Est: $0.80 | +3.7% | $434.9MEst: $431.5M | +0.8% |  10-K |
| Oct 30, 2025 | Q3 2025 | $0.54Est: $0.43 | +25.6% | $402.1MEst: $414.5M | -3.0% | 10-Q |
| Jul 31, 2025 | Q2 2025 | $0.45Est: $0.43 | +4.7% | $415.6MEst: $395.3M | +5.1% | 10-Q |
| May 5, 2025 | Q1 2025 | $0.41Est: $0.43 | -4.7% | $382.7MEst: $381.2M | +0.4% | 10-Q |
| Feb 25, 2025 | Q4 2024 | $0.97Est: $0.86 | +12.8% | $442.6MEst: $445.2M | -0.6% | 10-K |
| Nov 4, 2024 | Q3 2024 | $0.41Est: $0.39 | +5.1% | $380.8MEst: $375.8M | +1.3% | 10-Q |
| Jul 29, 2024 | Q2 2024 | $0.63Est: $0.62 | +1.6% | $418.2MEst: $413.2M | +1.2% | 10-Q |
| May 6, 2024 | Q1 2024 | $0.55Est: $0.55 | 0.0% | $368.9MEst: $362.0M | +1.9% | 10-Q |
| Feb 28, 2024 | Q4 2023 | $0.89Est: $0.90 | -1.1% | $397.0MEst: $399.3M | -0.6% | 10-K |
| Oct 25, 2023 | Q3 2023 | $0.76Est: $0.78 | -2.6% | $382.4MEst: $387.1M | -1.2% | 10-Q |
| Jul 26, 2023 | Q2 2023 | $0.71Est: $0.57 | +24.6% | $381.3MEst: $374.1M | +1.9% | — |
| Apr 26, 2023 | Q1 2023 | $0.74Est: $0.74 | 0.0% | $380.8MEst: $373.2M | +2.0% | — |